Humana (OM:HUM) - Cotización, noticias y análisis

Resumen de acción HUM

Humana AB (publ) presta servicios de atención individual y familiar a niños y adultos en Suecia, Finlandia, Noruega y Dinamarca.

Acerca de la empresa

HUM fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	3/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Recompensas

Cotiza un 70.2% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 26.37%

Cotiza a buen valor en comparación con empresas similares e industria

Análisis de riesgos

Los pagos de intereses no están bien cubiertos por los beneficios

Grandes partidas extraordinarias que afectan a los resultados financieros

Los márgenes de beneficio (1.5%) son inferiores a los del año pasado (2.4%)

Competidores de Humana AB (publ)

Ambea

OM:AMBEA

kr6.2b

Attendo

OM:ATT

kr7.0b

EQL Pharma

NGM:EQL

kr1.3b

C-Rad

OM:CRAD B

kr1.3b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Humana
Historical stock prices
Current Share Price	kr30.50
52 Week High	kr30.80
52 Week Low	kr13.96
Beta	0.76
1 Month Change	15.97%
3 Month Change	18.91%
1 Year Change	106.08%
3 Year Change	-57.10%
5 Year Change	-46.30%
Change since IPO	-58.78%

Noticias y actualizaciones recientes

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Recent updates

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Apr 09

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 12

Humana AB (publ)'s (STO:HUM) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 11

Did Humana AB (publ) (STO:HUM) Insiders Buy Up More Shares?

Feb 28

Do Humana's (STO:HUM) Earnings Warrant Your Attention?

Feb 15

Rentabilidad de los accionistas

	HUM	SE Healthcare	Mercado SE
7D	2.3%	5.5%	0.4%
1Y	106.1%	12.9%	11.4%

Rentabilidad vs. Industria: HUM superó al sector Swedish Healthcare , que obtuvo un rendimiento del 5.3% el año pasado.

Rentabilidad vs. Mercado: HUM superó al mercado Swedish, que obtuvo un rendimiento del 10.3% el año pasado.

Volatilidad de los precios

Is HUM's price volatile compared to industry and market?
HUM volatility
HUM Average Weekly Movement	6.7%
Healthcare Industry Average Movement	5.9%
Market Average Movement	6.3%
10% most volatile stocks in SE Market	13.5%
10% least volatile stocks in SE Market	3.6%

Precio estable de las acciones: HUM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de HUM (7%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2001	16,564	Johanna Rastad	www.humana.se

Humana AB (publ) presta servicios de atención individual y familiar a niños y adultos en Suecia, Finlandia, Noruega y Dinamarca. Opera a través de cinco segmentos: Individual y Familiar, Asistencia Personal, Cuidado de Ancianos, Finlandia y Noruega. La empresa ofrece atención y tratamiento para trastornos psicosociales, enfermedades mentales y discapacidad funcional; residencias de ancianos; servicios de atención familiar; viviendas para servicios especiales y de corta duración; servicios de atención ambulatoria; residencias asistidas; y viviendas especialmente adaptadas para personas con discapacidad funcional y escuelas de educación especial.

Resumen de fundamentos de Humana AB (publ)

¿Cómo se comparan los beneficios e ingresos de Humana con su capitalización de mercado?
Estadísticas fundamentales de HUM
Capitalización bursátil	kr1.46b
Beneficios(TTM)	kr146.00m
Ingresos (TTM)	kr9.62b

10.0x

Ratio precio-beneficio (PE)

0.2x

Ratio precio-ventas (PS)

¿Está HUM sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de HUM
Ingresos	kr9.62b
Coste de los ingresos	kr7.51b
Beneficio bruto	kr2.11b
Otros gastos	kr1.97b
Beneficios	kr146.00m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

Jul 19, 2024

Beneficios por acción (BPA)	3.05
Margen bruto	21.97%
Margen de beneficio neto	1.52%
Ratio deuda/patrimonio	72.1%

¿Cómo se ha desempeñado HUM a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción HUM

Recompensas

Análisis de riesgos

Competidores de Humana AB (publ)

OM:AMBEA

kr6.2b

OM:ATT

kr7.0b

NGM:EQL

kr1.3b

OM:CRAD B

kr1.3b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Humana AB (Publ) Announces CEO Changes

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Recent updates

Humana AB (Publ) Announces CEO Changes

First quarter 2024 earnings released: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

Investor sentiment improves as stock rises 15%

Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (Publ) Announces Nomination Committee for the Annual General Meeting 2024

Humana Announces Board Changes, Effective May 1, 2024

Consensus revenue estimates increase by 11%, EPS downgraded

Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Announces the Resignation of Johanna Rastad as President

Humana AB (publ) to Report Fiscal Year 2023 Results on Apr 03, 2024

New major risk - Revenue and earnings growth

Consensus EPS estimates increase by 15%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Humana AB (publ), Annual General Meeting, May 07, 2024

Humana AB (publ) to Report Q4, 2023 Results on Feb 08, 2024

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 23%

Price target increased by 41% to kr23.50

New major risk - Share price stability

Investor sentiment improves as stock rises 42%

Humana AB (publ) Announces Board Appointments

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 16%

Does Humana (STO:HUM) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS exceeds analyst expectations

Sören Mellstig Not Stands for the Re-Election to the Board of Humana AB (Publ)

Price target decreased by 23% to kr45.67

Humana AB (publ) to Report Fiscal Year 2022 Results on Apr 03, 2023

At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?

Investor sentiment deteriorates as stock falls 50%

Humana AB (publ) to Report Nine Months, 2023 Results on Nov 09, 2023

Price target decreased by 7.8% to kr59.33

Price target decreased to kr60.33

Humana AB (Publ) Announces Management Changes

Price target decreased to kr64.33

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana AB (publ) to Report Q1, 2023 Results on May 04, 2023

Sön Mellllstig, Chairman of the Board of Humana Ab, Is Not Available for Re-Election at the 2023 Annual General Meeting

Is Humana (STO:HUM) Using Too Much Debt?

Humana AB Announces Nomination Committee for 2023 AGM

Consensus forecasts updated

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman of the Board recently bought kr38m worth of stock

Noora Jayasekara Leaves Humana Member of Group Management

Humana AB (publ) (OM:HUM) acquired Vintergatan AB.

Humana AB (publ) (OM:HUM) completed the acquistion of Assistans For Dig I Sverige Ab.

Humana AB (publ) (OM:HUM) agreed to acquire Assistans For Dig I Sverige Ab for approximately SEK151 million.

Price target decreased to kr79.00

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to kr81.50

Full year 2021 earnings: Revenues in line with analyst expectations

Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?

Humana AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

President & CEO recently bought kr180k worth of stock

President & CEO recently bought kr200k worth of stock